article thumbnail

Women in Stem with Dr Rachel Lagiakos

Drug Target Review

Incredible advances in machine learning-driven tools allow us to predict the 3D structure of previously unsolved proteins, unlocking the power of structure-based drug design for drugging these targets, and most recently, the ability to predict protein assemblies, which contain both the protein and putative small molecule binders.

article thumbnail

Analysis Life Sciences Thank You FDA fiscal year in review: New drug approvals in the wake of the pandemic and legislative reforms

Agency IQ

For example, these products face a much more arduous path for development of biosimilar or interchangeable products than that of generics for small molecules. Amanda Conti, AgencyIQ Looking downstream, a shift toward biologics could have ripple effects for the life sciences industry.

FDA 52